RACHEL RATZLAFF: Open Payments
NPI 1275218612 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,263 in 160 payments from 28 companies in 2025. Trend: 2023 $888 · 2024 $3,361 · 2025 $3,263
Food & beverage: $3,263
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $561 |
| AstraZeneca Pharmaceuticals LP | 23 | $545 |
| Amgen Inc. | 23 | $237 |
| Lilly USA, LLC | 14 | $213 |
| Novo Nordisk Inc | 14 | $180 |
| Madrigal Pharmaceuticals | 7 | $170 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $136 |
| Novartis Pharmaceuticals Corporation | 5 | $126 |
| Astellas Pharma US Inc | 6 | $123 |
| PFIZER INC. | 6 | $116 |
Products named: VRAYLAR, BREZTRI, REZDIFFRA, MOUNJARO, Kerendia, QULIPTA, LEQVIO, Veozah.
Industry payments across CO — which companies pay providers there.
